87322937 - REPLIMUNE

Information

• Trademark
• 87322937

• Source

• Serial Number

  87322937

• Registration Number

  5353768

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 02, 2017
  8 years ago

• Registration Date

  December 12, 2017
  7 years ago

• Transaction Date

  October 01, 2024
  5 months ago

• Status Date

  August 26, 2024
  7 months ago

• Published for Opposition Date

  September 26, 2017
  7 years ago

• Location Date

  August 26, 2024
  7 months ago

• Status Code

  705

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  JOHNSON, CLINTON

• Attorney Docket Number

  221834-00009

  Attorney Name

  Melanie Howard

• Owners

  • Replimune Limited

Case File Statements

• B00001: In the statement, "REG. NO. UK0000320659" should be deleted, and UK0003206593 should be inserted.
• GS0051: Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of [ infectious, ]oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, namely, [ anti-infectives ] for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, namely, pharmaceuticals for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system ] diseases and disorders
• GS0421: [ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines ]

Case File Event Statements

• 5/4/2017 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/6/2017 - 8 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/7/2017 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/27/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/4/2017 - 7 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/4/2017 - 7 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/11/2017 - 7 years ago

  7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/19/2017 - 7 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/4/2017 - 7 years ago

  9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/4/2017 - 7 years ago

  10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/14/2017 - 7 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 8/14/2017 - 7 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/14/2017 - 7 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/18/2017 - 7 years ago

  14 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 8/19/2017 - 7 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/6/2017 - 7 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/26/2017 - 7 years ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/26/2017 - 7 years ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/12/2017 - 7 years ago

  19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/20/2018 - 7 years ago

  20 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 3/28/2018 - 7 years ago

  21 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/11/2018 - 6 years ago

  22 - POST REGISTRATION ACTION MAILED - SEC. 7 Type: PRAM

• 9/10/2018 - 6 years ago

  23 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 9/20/2018 - 6 years ago

  24 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.

• 9/4/2020 - 4 years ago

  25 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.

• 6/12/2024 - 9 months ago

  28 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 8/26/2024 - 7 months ago

  29 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 8/26/2024 - 7 months ago

  30 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 12/6/2023 - a year ago

  27 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 12/12/2022 - 2 years ago

  26 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1